Cargando…
Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology
Hepatic fibrosis is a major cause of morbidity and mortality worldwide, as it ultimately leads to cirrhosis, which is estimated to affect up to 2% of the global population. Hepatic fibrosis is confirmed by liver biopsy, and the erroneous nature of this technique necessitates the search for noninvasi...
Autores principales: | Chang, Ming-Ling, Yang, Sien-Sing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912636/ https://www.ncbi.nlm.nih.gov/pubmed/31726658 http://dx.doi.org/10.3390/cells8111423 |
Ejemplares similares
-
Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression
por: Chang, Ming-Ling, et al.
Publicado: (2020) -
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019) -
PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics
por: Ying, Hua-Zhong, et al.
Publicado: (2017) -
Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018) -
Common pathway signature in lung and liver fibrosis
por: Makarev, Eugene, et al.
Publicado: (2016)